Platform
Connect, Interpret, Orchestrate, Measure — the clinical intelligence platform behind every workflow.
Explore the platform →Turn unstructured faxes, specialist reports and historical charts into complete, usable clinical evidence and eligible EHR updates—so teams recover documented care, reduce repeated review and measure the value delivered.
Better information. Less manual work. More effective value-based care.
Explore Odesso Outcomes →Completeness is evaluated within the records authorized and available to Odesso; it is not a promise that every record exists or is complete.
Odesso is a multi-specialty clinical intelligence and workflow orchestration platform. It transforms clinical information buried in PDFs, faxes, outside medical records, and existing charts into actionable intelligence across your patient population.
Identify qualifying quality-measure evidence. Surface documented clinical complexity relevant to risk adjustment. Reduce manual chart review and repetitive data entry.
And unlike workflows that stop at a dashboard or recommendation, Odesso autonomously writes protocol-qualified clinical information into supported structured EHR fields, making it available at the source for the clinical, quality, risk, and AI systems that depend on it.
Four named solutions share one platform and one governed write-back path.
Connect, Interpret, Orchestrate, Measure — the clinical intelligence platform behind every workflow.
Explore the platform →Continuous intelligence for incoming document work — fewer repeat touches on faxes, outside records and specialist reports.
Explore PowerInbox →Historical evidence recovery across your population — reduce large-scale manual retrospective chart review.
Explore retrospective intelligence →Source-linked clinical evidence for qualified review across quality, risk and care workflows.
Explore Risk & Quality Intelligence →Other organization references in prior materials reflect team experience and do not establish an active Odesso customer or technology partnership.
See the workflow →Recognize completed care. Surface documented complexity. Release teams from repetitive clinical-data work.
Recover qualifying evidence from historical and incoming records to support HEDIS, NCQA, MIPS, UDS and applicable payer quality workflows.
Measure: evidence recovered · Supported updates · Review effort · Reporting-data availability
Clinical evidence must satisfy the applicable measure-year requirements. Downstream acceptance is verified separately.
Your organization has invested in EHRs, quality platforms and clinical AI. Yet a retinal exam, ejection fraction or kidney result may remain in an attachment rather than the structured fields those systems need.
A retinal examination is documented, but its date and result are absent from the fields read by a quality workflow.
Reviewers reopen documents and transcribe evidence that another team may already have found.
Relevant clinical information may remain unavailable to downstream workflows that rely on those fields.
Competitor workflows vary; this compares operating paths, not all vendors.
Follow clinical evidence from a document into the structured chart. See the routine automated path and how conflicts are routed to human review.
Retinal exam — the complete chain at a glance:
eGFR 62 mL/min/1.73m² and uACR 18 mg/g, and LVEF 55% follow the same six stages. Enable JavaScript for the step-through view with the exception branch.
Illustrative workflow visualization. This is not a live EHR screen or a customer production recording.
Outside documents and the chart itself — PDFs, faxes, specialist reports, existing EHR data.
Specialty-specific clinical protocols and measure-year logic evaluate each finding.
Complete eligible structured chart updates autonomously, without approval of each routine result. Verify persistence; route exceptions for review.
Persisted values, exception rates, reviewer effort — verified effects only.
Bring a priority workflow. Establish the baseline, verify the work completed, and measure the benefit to your team.
“Demonstrated excellent ability to reconcile unstructured clinical evidence into credible submissions to CMS.”
“Demonstrated deep technical expertise for launching quality and risk intelligence platforms.”
“Dedicated and deeply knowledgeable, not only in clinical workflow but in realizing ROI.”
During discovery and implementation planning, agree on one priority workflow, a baseline, a measurement period and acceptance criteria. After implementation, compare verified work, rework, actual cash savings and net benefit after fees.
Repeated chart review, extraction and correction create recurring administrative costs. Automating qualifying updates can reduce repeat-review burden and improve staff utilization.
Measure: Hours released · Cost per review · Verified net operational benefit
Estimate Your Operational ValueA retrospective review may solve today’s reporting problem while leaving the source record incomplete. A supported source-level update can reduce repeated downstream work.
Document arrives → reviewer searches → evidence enters a report → another team validates or transcribes it. The original structured record may still be incomplete.
Document arrives → qualifying evidence is validated → supported fields update autonomously → persistence is verified. Exceptions go to review.
Some measures require fresh evidence each measurement period. Persisting a clinical fact does not guarantee future-year qualification, payer acceptance or financial return.
A proposed optional model combining a platform fee with payment for agreed, verified workflow results. Scope, eligibility and commercial terms are defined after qualification.
A defined administrative workflow is completed correctly, with exceptions and rework tracked.
Previously documented care is recovered and accepted by the receiving quality workflow.
Incremental improvement is confirmed against an agreed baseline, with attribution and customer validation.
An Outcome Token is a contractual accounting unit for an eligible verified event—not an AI compute token. Recovered evidence, newly completed care and downstream clinical outcomes are measured separately.
| Pilot workflow | Completion evidence |
|---|---|
| Inbox automation | Correct classification and routing or a supported EHR update, with completion verified and rework tracked. |
| Quality evidence recovery | Source-linked evidence accepted under the agreed program and measurement-year rules. |
Pilot design: agree on baseline, eligible events, exclusions, source traceability, customer validation, attribution, duplicate handling and payment-dispute rules before launch. Count each eligible event once under the agreement.
Verification: an EHR update is verified when the value persists. Quality evidence and gap closure require separate confirmation from the receiving payer or program. Available confirmation and integration requirements are established during pilot scoping.
Proposed optional model. Commercial terms and any evaluation are scoped after qualification and agreed in writing.
Compare manual work, AI-assisted abstraction and Odesso's autonomous workflow using the same volume and assumptions.
Count each completed workflow once. Use the same scope and period as your costs. This input does not infer payer acceptance or gap closure.
Enter confirmed counts for the same model period. These can overlap with EHR updates; they are not added together or used to infer revenue.
Total modeled Odesso cost divided by the selected confirmed event count. This allocates full cost to one event type; it is not a separate charge.
Enter costs and optional revenue for the selected period. In the assisted scenario, extraction is automated, but every finding still receives review and structured entry. In the autonomous scenario, eligible routine findings bypass those steps; ineligible findings retain the manual path and eligible exceptions receive review and entry.
Realizable spending reduction is the share of released labor capacity that you can actually remove from spending. It defaults to 0%. Quality and risk revenue are user-entered incremental opportunities, not guaranteed results or inferred from recovered gaps.
Net financial impact = realizable cash savings + optional incremental revenue − incremental implementation and service costs. Labor capacity value is shown separately and is not added again to net return. Compare workflows for equivalent scope. This planning model is not a quote or forecast.
Use discovery to agree on the need, confirm solution fit and define measurable value. Implementation scope and evaluation options follow qualification.
Find the measure by name, its program identifier, and the clinical evidence that needs to reach the chart.
CMS and UDS identifiers below use 2026 versions. HEDIS entries are measure families; the applicable measurement-year specification governs. Evidence recovery does not by itself establish a complete measure result or an available write-back mapping.
Browse the named measures below.
| Measure | Program / ID | Clinical evidence |
|---|---|---|
| Controlling High Blood Pressure | HEDIS CBP | Dated systolic / diastolic readings |
| Glycemic Status Assessment for Patients With Diabetes | HEDIS GSD | HbA1c or GMI results and dates |
| Eye Exam for Patients With Diabetes | HEDIS EED | Retinal exam date, result and retinopathy documentation |
| Kidney Health Evaluation for Patients With Diabetes | HEDIS KED | eGFR and uACR results with dates |
| Breast Cancer Screening | HEDIS BCS-E | Mammography completion and date |
| Colorectal Cancer Screening | HEDIS COL-E | Colonoscopy, FIT / FOBT, stool DNA or other qualifying screening |
| Cervical Cancer Screening | HEDIS CCS-E | Cytology / high-risk HPV results and dates |
| Adult Immunization Status | HEDIS AIS-E | Vaccination type, administration date and source |
| Care for Older Adults | HEDIS COA | Medication review and functional assessment evidence |
| Transitions of Care | HEDIS TRC | Discharge, follow-up and medication reconciliation records |
| Osteoporosis Management in Women Who Had a Fracture | HEDIS OMW | Fracture history, bone-density testing and treatment documentation |
| Diabetes: Glycemic Status Assessment Greater Than 9% | CMS eCQMs / MIPS CMS122v14 · Q001 | Dated HbA1c / GMI values |
| Diabetes: Eye Exam | CMS eCQMs / MIPS CMS131v14 · Q117 | Retinal examination and retinopathy evidence |
| Kidney Health Evaluation | CMS eCQMs / MIPS CMS951v4 | eGFR and uACR results |
| Controlling High Blood Pressure | CMS eCQMs / MIPS CMS165v14 · Q236 | Dated systolic / diastolic values |
| Breast Cancer Screening | CMS eCQMs / MIPS CMS125v14 · Q112 | Mammography completion date |
| Colorectal Cancer Screening | CMS eCQMs / MIPS CMS130v14 · Q113 | Screening type and completion date |
| Cervical Cancer Screening | CMS eCQMs / MIPS CMS124v14 · Q309 | Cytology / HPV evidence |
| Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS eCQMs / MIPS CMS347v9 | Medication and clinician documentation |
| Falls: Screening for Future Fall Risk | CMS eCQMs / MIPS CMS139v14 · Q318 | Documented fall-risk screening |
| Childhood Immunization Status | UDS CMS117v14 | Vaccine type and administration dates |
| Cervical Cancer Screening | UDS CMS124v14 | Cytology / HPV reports |
| Breast Cancer Screening | UDS CMS125v14 | Mammography reports |
| Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents | UDS CMS155v14 | BMI percentile and counseling documentation |
| Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | UDS CMS69v14 | Height, weight, BMI and follow-up evidence |
| Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | UDS CMS138v14 | Tobacco screening and intervention documentation |
| Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | UDS CMS347v9 | Medication and clinician documentation |
| Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet | UDS CMS164v7 | Medication and relevant vascular history |
| Colorectal Cancer Screening | UDS CMS130v14 | Screening type and completion date |
| Preventive Care and Screening: Screening for Depression and Follow-Up Plan | UDS CMS2v15 | Screening score, date and follow-up plan |
| Controlling High Blood Pressure | UDS CMS165v14 | Dated systolic / diastolic values |
| Diabetes: Glycemic Status Assessment Greater Than 9% | UDS CMS122v14 | Dated HbA1c / GMI values |
| Documented CKD stage | Risk review evidence No automatic diagnosis or HCC assignment | Nephrology consult; clinician-confirmed CKD stage with date and source |
| Heart failure and cardiac findings | Risk review evidence No automatic diagnosis or HCC assignment | Cardiology note and echo report; documented condition, dated LVEF and clinical context |
| Diabetes with documented complications | Risk review evidence No automatic diagnosis or HCC assignment | Clinician documentation linking diabetes and the documented complication |
| Chronic pulmonary disease | Risk review evidence No automatic diagnosis or HCC assignment | Pulmonary consult, PFT report and clinician-documented condition |
Catalog entries describe evidence types, not confirmed production mappings. EHR destination, program year and deployment status must be confirmed for each implementation. Suspected conditions and clinical observations remain distinct from provider-confirmed diagnoses. Payer-specific requirements are reviewed during discovery.
No matching measures. Try another program or search term.
Program references: NCQA HEDIS · CMS 2026 eCQMs · HRSA 2026 UDS
Discuss my measures and EHR workflowFrom echocardiograms to retinal examinations and renal labs: specialty-specific protocols turn qualifying evidence into usable chart data where the EHR and workflow permit. Explore the clinical evidence and chart updates relevant to your specialty.
Additional candidate groupings under evaluation — each requires workflow mapping before any deployment:
Oncology / Hematology · Pathology / Lab · Radiology / Imaging · Orthopedics / Spine · Rheumatology · Neurology / Neurosurgery / Pain · ENT / Allergy · Urology · Dermatology / Mohs · Perioperative · Emergency / Urgent Care
Candidate examples only; never a statement of production support.
Multiple departments re-review the same charts, paying repeatedly for evidence already documented. Source-level structured updates reduce repeat abstraction and give governed, auditable rollout across affiliated practices.
Explore Health SystemsQuality and risk performance depends on documentation that stays locked in scanned records — a direct cost to risk-bearing entities. Recover qualifying evidence and complete documentation at panel scale, measured against agreed baselines.
Explore MSOs & ACOsSpecialist findings sit in PDFs and faxes while referring workflows re-request the same information. Specialty protocols turn qualifying findings into structured data your referring partners can use.
Explore Specialty GroupsProvider data completeness constrains Stars and risk-adjustment performance across the network. Improve source-level evidence availability with authorized access only — no unauthorized provider-chart access.
Explore Payers & Health PlansDetails at the Trust Center. Explore our security and privacy commitments.
Ground your discovery conversation in the current applicable requirements. Programs and rules change—confirm the requirements that apply to your organization.
Company resources first. Items labeled external are independent industry reading, not Odesso news.
Improve quality-data completeness, strengthen risk-documentation workflows and reduce repetitive clinical-data work—with autonomous last-mile execution inside supported EHR fields. Bring your highest-priority workflow.
See Odesso in Action